OrbiMed’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-8,170,973
| Closed | -$23.5M | – | 145 |
|
|
2017
Q4 | $23.5M | Sell |
8,170,973
-4,891,927
| -37% | -$14.1M | 0.3% | 74 |
|
|
2017
Q3 | $58.7M | Sell |
13,062,900
-44,300
| -0.3% | -$199K | 0.56% | 53 |
|
|
2017
Q2 | $60.2M | Hold |
13,107,200
| – | – | 0.63% | 49 |
|
|
2017
Q1 | $55.2M | Hold |
13,107,200
| – | – | 0.63% | 48 |
|
|
2016
Q4 | $54.1M | Hold |
13,107,200
| – | – | 0.69% | 47 |
|
|
2016
Q3 | $106M | Buy |
13,107,200
+1,425,600
| +12% | +$11.5M | 1.21% | 28 |
|
|
2016
Q2 | $91.1M | Buy |
11,681,600
+161,900
| +1% | +$1.26M | 0.95% | 37 |
|
|
2016
Q1 | $88.9M | Buy |
11,519,700
+1,869,800
| +19% | +$14.4M | 0.94% | 33 |
|
|
2015
Q4 | $104M | Buy |
9,649,900
+4,427,400
| +85% | +$47.8M | 0.94% | 36 |
|
|
2015
Q3 | $36.1M | Buy |
+5,222,500
| New | +$36.1M | 0.36% | 55 |
|
|
2015
Q2 | – | Sell |
-158,000
| Closed | -$1.56M | – | 145 |
|
|
2015
Q1 | $1.56M | Hold |
158,000
| – | – | 0.01% | 121 |
|
|
2014
Q4 | $1.94M | Hold |
158,000
| – | – | 0.02% | 113 |
|
|
2014
Q3 | $1.58M | Buy |
+158,000
| New | +$1.58M | 0.02% | 114 |
|
|
2013
Q3 | – | Sell |
-545,000
| Closed | -$4.46M | – | 121 |
|
|
2013
Q2 | $4.46M | Buy |
+545,000
| New | +$4.46M | 0.09% | 92 |
|